TY  - JOUR
AU  - Gutierrez-Valencia, Alicia
AU  - Benmarzouk-Hidalgo, Omar J.
AU  - Rivas-Jeremias, Inmaculada
AU  - Espinosa, Nuria
AU  - Trujillo-Rodriguez, Maria
AU  - Fernandez-Magdaleno, Tamara
AU  - Viciana, Pompeyo
AU  - Lopez-Cortes, Luis F.
PY  - 2017
DO  - 10.1093/cid/cix358
SN  - 1058-4838
UR  - http://hdl.handle.net/10668/18939
T2  - Clinical infectious diseases
AB  - Background. There are several regimens for starting antiretroviral treatment, but it remains unknown whether either of them is more advantageous regarding the time course and magnitude of human immunodeficiency virus (HIV) RNA decay in...
LA  - en
PB  - Oxford univ press inc
KW  - HIV-1
KW  - semen
KW  - male genital tract
KW  - antiretroviral treatment
KW  - Co-formulated elvitegravir
KW  - Hiv-1 rna
KW  - Initial treatment
KW  - Double-blind
KW  - Wild-type
KW  - Rilpivirine
KW  - Blood
KW  - Emtricitabine
KW  - Dolutegravir
KW  - Compartments
TI  - Viral Kinetics in Semen With Different Antiretroviral Families in Treatment-Naive Human Immunodeficiency Virus-Infected Patients: A Randomized Trial
TY  - research article
VL  - 65
ER  -